The promised layoffs at Atara Biotherapeutics have begun weeks after the Bay Area company announced plans to terminate 20% of its staff under a new corporate strategy focused on the innovation within the company’s pipeline.
https://www.pharmalive.com/wp-content/uploads/2022/08/BioSpacePascalTouchon.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-08-24 11:39:492022-08-24 11:39:4977 jobs on the chopping block as Atara pivots pipeline strategy